| Income Statement | 2026-03-31 | |||
|---|---|---|---|---|
| Revenues | 1,141,607 | |||
| Cost of sales | 386,856 | |||
| Gross profit | 754,751 | |||
| Sales and marketing | 3,069,104 | |||
| Research and development | 1,415,032 | |||
| General and administrative | 4,333,577 | |||
| Impairment expense | 1,000,000 | |||
| Total operating expenses | 9,817,713 | |||
| Operating loss | -9,062,962 | |||
| Loss on disposal of assets | -149,125 | |||
| Unrealized loss on change in derivative liabilities | -320,404 | |||
| Other income | 111,517 | |||
| Interest income | 13,099 | |||
| Interest expense | 1,065,797 | |||
| Total other income (expense) | -1,410,710 | |||
| Loss before taxes | -10,473,672 | |||
| Net loss | -10,473,672 | |||
| Less series b preferred stock dividends | 403,603 | |||
| Net loss available to common stockholders | -10,877,275 | |||
| Basic EPS | -0.38 | |||
| Diluted EPS | -0.38 | |||
| Basic Average Shares | 30,154,631 | |||
| Diluted Average Shares | 30,154,631 | |||
PetVivo Holdings, Inc. (PETV)
PetVivo Holdings, Inc. (PETV)